Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer
- KEYNOTE-181 Investigators
- National Cancer Center Japan
- Cornell University
- Aichi Cancer Center Hospital and Research Institute
- Centre Antoine Lacassagne
- Université de Montpellier
- National Taiwan University
- University of Tsukuba
- University of Ulsan
- Institut de Cancérologie de l'Ouest
- Peking University
- Harvard University
- PLA Cancer Centre of Nanjing Bayi Hospital
- Instituto Português de Oncologia do Porto Francisco Gentil E.P.E.
- Jiangsu Institute of Cancer Institute & Hospital
- Hospital de Base
- Centre Léon Bérard
- Centre Georges-François Leclerc
- University of Kansas Cancer Center
- University Cancer Center Leipzig
- Merck
- CHU de Brest
Research output: Contribution to journal › Article › peer-review
937
Link opens in a new tab
Scopus
citations